- Home
- AIXI vs BNR Comparison
AIXI vs BNR Comparison
Compare AIXI & BNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIXI
- BNR
- Stock Information
- Founded
- AIXI 2001
- BNR 2014
- Country
- AIXI China
- BNR China
- Employees
- AIXI N/A
- BNR N/A
- Industry
- AIXI Computer Software: Prepackaged Software
- BNR Medical Specialities
- Sector
- AIXI Technology
- BNR Health Care
- Exchange
- AIXI Nasdaq
- BNR Nasdaq
- Market Cap
- AIXI 31.2M
- BNR 38.3M
- IPO Year
- AIXI 2023
- BNR 2020
- Fundamental
- Price
- AIXI $2.01
- BNR $4.60
- Analyst Decision
- AIXI
- BNR
- Analyst Count
- AIXI 0
- BNR 0
- Target Price
- AIXI N/A
- BNR N/A
- AVG Volume (30 Days)
- AIXI 138.1K
- BNR 29.7K
- Earning Date
- AIXI 05-15-2025
- BNR 08-21-2025
- Dividend Yield
- AIXI N/A
- BNR N/A
- EPS Growth
- AIXI N/A
- BNR N/A
- EPS
- AIXI N/A
- BNR N/A
- Revenue
- AIXI $70,314,315.00
- BNR $72,112,038.00
- Revenue This Year
- AIXI $26.84
- BNR $136.32
- Revenue Next Year
- AIXI N/A
- BNR N/A
- P/E Ratio
- AIXI N/A
- BNR N/A
- Revenue Growth
- AIXI 18.84
- BNR 0.53
- 52 Week Low
- AIXI $2.06
- BNR $2.18
- 52 Week High
- AIXI $8.31
- BNR $7.90
- Technical
- Relative Strength Index (RSI)
- AIXI 41.81
- BNR 63.77
- Support Level
- AIXI $2.20
- BNR $3.06
- Resistance Level
- AIXI $2.60
- BNR $3.50
- Average True Range (ATR)
- AIXI 0.31
- BNR 0.21
- MACD
- AIXI -0.01
- BNR 0.05
- Stochastic Oscillator
- AIXI 23.33
- BNR 95.65
About AIXI XIAO-I Corporation
XIAO-I Corp is an AI industrialization company focusing on the AI Cognitive Intelligence platform. The platform combines six core technologies including Natural Language Processing, Speech Processing, Computer Vision, Machine Learning, Affective Computing, Data Intelligence, and Hyper- automation. Based on the platform, The company developed products and solutions in the fields of Al+ Contact Center, Al+ Finance, Al+ City Public Service, Al+ Architecture, Al+ Metaverse, Al+ Manufacturing, and Al+ Healthcare. It generates revenue from the sale of software products and services, M&S services, and the sale of cloud platform products.
About BNR Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.